{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:48:50Z","timestamp":1793407730248,"version":"4.5.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN-408093"],"award-info":[{"award-number":["FRN-408093"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["J3-1755"],"award-info":[{"award-number":["J3-1755"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["MSCA-RISE TRENDO (101008193)"],"award-info":[{"award-number":["MSCA-RISE TRENDO (101008193)"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Endometriosis (EM) is an estrogen-dominant inflammatory disease linked to infertility that affects women of reproductive age. EM lesions respond to hormonal signals that regulate uterine tissue growth and trigger inflammation and pain. The objective of this study was to evaluate whether estradiol (E<jats:sub>2<\/jats:sub>) and its biologically active metabolites are differentially associated with EM given their estrogenic and non-estrogenic actions including proliferative and inflammatory properties.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>We performed a retrospective study of 209 EM cases and 115 women without EM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Pain-related outcomes were assessed using surveys with validated scales. Preoperative serum levels of estradiol (E<jats:sub>2<\/jats:sub>) and estrone (E<jats:sub>1<\/jats:sub>), their 2-, 4- and 16- hydroxylated (OH) and methylated (MeO) derivatives (n=16) were measured by mass spectrometry. We evaluated the associations between estrogen levels and EM anatomic sites, surgical stage, risk of EM, and symptoms reported by women. Spearman correlations established the relationships between circulating steroids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the sixteen estrogens profiled, eleven were detected above quantification limits in most individuals. Steroids were positively correlated, except 2-hydroxy 3MeO-E<jats:sub>1<\/jats:sub> (2OH-3MeO-E<jats:sub>1<\/jats:sub>). Higher 2OH-3MeO-E<jats:sub>1<\/jats:sub> was linked to an increased risk of EM (Odd ratio (OR)=1.91 (95%CI 1.09-3.34); <jats:italic>P<\/jats:italic>=0.025). Ovarian EM cases displayed enhanced 2-hydroxylation with higher 2MeO-E<jats:sub>1<\/jats:sub> and 2OH-E<jats:sub>1<\/jats:sub> levels (<jats:italic>P<\/jats:italic>&amp;lt; 0.009). Abdominal, pelvic and back pain symptoms were also linked to higher 2OH-3MeO-E<jats:sub>1<\/jats:sub> levels (OR=1.86; 95%CI 1.06-3.27; <jats:italic>P<\/jats:italic>=0.032).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The 2-hydroxylation pathway emerges as an unfavorable feature of EM, and is associated with ovarian EM and pain related outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1034614","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T15:39:07Z","timestamp":1674056347000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Circulating estradiol and its biologically active metabolites in endometriosis and in relation to pain symptoms"],"prefix":"10.3389","volume":"13","author":[{"given":"Jean-Philippe","family":"Emond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Pu\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Turcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Simonyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Vogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u0161ko","family":"Osredkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea Lani\u0161nik","family":"Riz\u030cner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Guillemette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16447","article-title":"Prevalence and incidence of endometriosis in Australian women: A data linkage cohort study","volume":"128","author":"Rowlands","year":"2021","journal-title":"Bjog"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew293","article-title":"World endometriosis society consensus on the classification of endometriosis","volume":"32","author":"Johnson","year":"2017","journal-title":"Hum Reprod"},{"key":"B3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/jwh.2017.6397","article-title":"Quality of life in women with endometriosis: An integrative review","volume":"27","author":"Marinho","year":"2018","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bpobgyn.2018.06.002","article-title":"Endometriosis and infertility: Insights into the causal link and management strategies","volume":"51","author":"Tomassetti","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.07.1061","article-title":"Deep endometriosis: definition, diagnosis, and treatment","volume":"98","author":"Koninckx","year":"2012","journal-title":"Fertil Steril"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(97)00191-X","article-title":"Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities","volume":"68","author":"Nisolle","year":"1997","journal-title":"Fertil Steril"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-018-0008-5","article-title":"Endometriosis","volume":"4","author":"Zondervan","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.3390\/ijms20225615","article-title":"The pathogenesis of endometriosis: Molecular and cell biology insights","volume":"20","author":"Lagana","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.04.041","article-title":"Endometriosis: Etiology, pathobiology, and therapeutic prospects","volume":"184","author":"Saunders","year":"2021","journal-title":"Cell"},{"key":"B10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.mce.2005.11.041","article-title":"Progesterone resistance in endometriosis: link to failure to metabolize estradiol","volume":"248","author":"Bulun","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-1692","article-title":"Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis","volume":"148","author":"Burney","year":"2007","journal-title":"Endocrinology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.950866","article-title":"Is intracrinology of endometriosis relevant in clinical practice? a systematic review on estrogen metabolism","volume":"13","author":"Mercorio","year":"2022","journal-title":"Front Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.04.012","article-title":"Estradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis","volume":"185","author":"Greaves","year":"2015","journal-title":"Am J Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082815","article-title":"Estrogen receptors and endometriosis","volume":"21","author":"Chantalat","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00935","article-title":"Regulation of inflammation pathways and inflammasome by sex steroid hormones in endometriosis","volume":"10","author":"Garcia-Gomez","year":"2019","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13743","article-title":"Aromatase as a target for treating endometriosis","volume":"44","author":"Mori","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.1.8550748","article-title":"Aromatase expression in endometriosis","volume":"81","author":"Noble","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.12.5301","article-title":"Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol","volume":"83","author":"Zeitoun","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"Cd012165","DOI":"10.1002\/14651858.CD012165","article-title":"Endometrial biomarkers for the non-invasive diagnosis of endometriosis","volume":"4","author":"Gupta","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1586\/14737159.2014.899905","article-title":"Noninvasive biomarkers of endometriosis: myth or reality","volume":"14","author":"Rizner","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"key":"B22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40169-016-0088-3","article-title":"Depurinating estrogen-DNA adducts, generators of cancer initiation: Their minimization leads to cancer prevention","volume":"5","author":"Cavalieri","year":"2016","journal-title":"Clin Transl Med"},{"key":"B23","article-title":"Catechol-o-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms","volume":"61","author":"Dawling","year":"2001","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/en.2006-0113","article-title":"Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding","volume":"147","author":"Zhu","year":"2006","journal-title":"Endocrinology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/368237a0","article-title":"The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth","volume":"368","author":"Fotsis","year":"1994","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1137094","article-title":"The estrogen metabolites 2-methoxyestradiol and 2-hydroxyestradiol inhibit endometriotic cell proliferation in estrogen-receptor-independent manner","volume":"32","author":"Samartzis","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s004320000233","article-title":"The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors","volume":"127","author":"Schumacher","year":"2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0039-128X(80)90062-8","article-title":"Comparative properties of the catechol estrogens, I: Methylation by catechol-o-methyltransferase and binding to cytosol estrogen receptors","volume":"36","author":"Merriam","year":"1980","journal-title":"Steroids"},{"key":"B29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jsbmb.2017.10.021","article-title":"Estradiol metabolites as biomarkers of endometrial cancer prognosis after surgery","volume":"178","author":"Audet-Delage","year":"2018","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41416-021-01376-z","article-title":"Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression","volume":"125","author":"Emond","year":"2021","journal-title":"Br J Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.6.1415","article-title":"What makes a good case-control study? design issues for complex traits such as endometriosis","volume":"17","author":"Zondervan","year":"2002","journal-title":"Hum Reprod"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2017-0426","article-title":"Models including serum CA-125, BMI, cyst pathology, dysmenorrhea or dyspareunia for diagnosis of endometriosis","volume":"12","author":"Knific","year":"2018","journal-title":"Biomark Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2015.01.006","article-title":"Panels of cytokines and other secretory proteins as potential biomarkers of ovarian endometriosis","volume":"17","author":"Kocbek","year":"2015","journal-title":"J Mol Diagn"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des152","article-title":"Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis","volume":"27","author":"Vouk","year":"2012","journal-title":"Hum Reprod"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/aogs.12026","article-title":"The rASRM score and the enzian classification for endometriosis: Their strengths and weaknesses","volume":"92","author":"Haas","year":"2013","journal-title":"Acta Obstet Gynecol Scand"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2008.09.056","article-title":"Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. report from the art and science of endometriosis meeting","volume":"93","author":"Vincent","year":"2010","journal-title":"Fertil Steril"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu046","article-title":"Systematic review of endometriosis pain assessment: How to choose a scale","volume":"21","author":"Bourdel","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1154","article-title":"Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels","volume":"97","author":"Huhtinen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00054.2015","article-title":"Aromatase: Contributions to physiology and disease in women and men","volume":"31","author":"Blakemore","year":"2016","journal-title":"Physiol (Bethesda)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00030","article-title":"The important roles of steroid sulfatase and sulfotransferases in gynecological diseases","volume":"7","author":"Ri\u017ener","year":"2016","journal-title":"Front Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/me.2006-0302","article-title":"Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis","volume":"22","author":"Utsunomiya","year":"2008","journal-title":"Mol Endocrinol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-0031-1299596","article-title":"Role of estrogen receptor-beta in endometriosis","volume":"30","author":"Bulun","year":"2012","journal-title":"Sem Rep Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2218","article-title":"Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism","volume":"94","author":"Delvoux","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12285","article-title":"Local estrogen formation and its regulation in endometriosis","volume":"18","author":"Mori","year":"2019","journal-title":"Reprod Med Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":":1123","DOI":"10.3390\/cells8101123","article-title":"Estrogen-receptor expression and function in female reproductive disease","volume":"8","author":"Tang","year":"2019","journal-title":"Cells"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz005","article-title":"Endometriosis and nuclear receptors","volume":"25","author":"Yilmaz","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/09513590601152219","article-title":"Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis","volume":"23","author":"Smuc","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mce.2008.09.019","article-title":"Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer","volume":"301","author":"Smuc","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mce.2009.03.022","article-title":"Estrogen metabolism and action in endometriosis","volume":"307","author":"Rizner","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mce.2012.12.019","article-title":"Disturbed balance between phase I and II metabolizing enzymes in ovarian endometriosis: a source of excessive hydroxy-estrogens and ROS","volume":"367","author":"Hevir","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s43032-020-00383-4","article-title":"Markers of local and systemic estrogen metabolism in endometriosis","volume":"28","author":"Othman","year":"2021","journal-title":"Reprod Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29252\/ijrm.14.1.1","article-title":"(1)H NMR- based metabolomics approaches as non- invasive tools for diagnosis of endometriosis","volume":"14","author":"Ghazi","year":"2016","journal-title":"Int J Reprod BioMed"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1530\/REP-15-0581","article-title":"Increased expression of CYP1A1 and CYP1B1 in ovarian\/peritoneal endometriotic lesions","volume":"151","author":"Piccinato","year":"2016","journal-title":"Reproduction"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.143","article-title":"Cancer, inflammation, and therapy: effects on cytochrome p450-mediated drug metabolism and implications for novel immunotherapeutic agents","volume":"96","author":"Harvey","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.07.026","article-title":"Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer","volume":"381","author":"Ri\u017ener","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.10.034","article-title":"Estrogen receptor \u03b2 modulates apoptosis complexes and the inflammasome to drive the pathogenesis of endometriosis","volume":"163","author":"Han","year":"2015","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/me.2013-1421","article-title":"ER\u03b2- and prostaglandin E2-regulated pathways integrate cell proliferation via ras-like and estrogen-regulated growth inhibitor in endometriosis","volume":"28","author":"Monsivais","year":"2014","journal-title":"Mol Endocrinol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","article-title":"Inflammation in the pathophysiology of neuropathic pain","volume":"159","author":"Sommer","year":"2018","journal-title":"Pain"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2009.06.017","article-title":"Endometriosis and mechanisms of pelvic pain","volume":"16","author":"Howard","year":"2009","journal-title":"J Minim Invasive Gynecol"},{"key":"B60","doi-asserted-by":"publisher","first-page":":2296","DOI":"10.3390\/ijms18112296","article-title":"Pharmacological regulation of neuropathic pain driven by inflammatory macrophages","volume":"18","author":"Kiguchi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B61","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13293-021-00364-5","article-title":"Estrogen receptors in pain modulation: Cellular signaling","volume":"12","author":"Chen","year":"2021","journal-title":"Biol Sex Differ"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.107.061804","article-title":"Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis","volume":"77","author":"Xue","year":"2007","journal-title":"Biol Reprod"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2011.03.010","article-title":"Novel estrogen-related genes and potential biomarkers of ovarian endometriosis identified by differential expression analysis","volume":"125","author":"Vouk","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.fertnstert.2020.01.036","article-title":"Estrogen receptor-\u03b1 immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis","volume":"113","author":"Pluchino","year":"2020","journal-title":"Fertil Steril"},{"key":"B65","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clinbiochem.2018.03.012","article-title":"Fertility and infertility: Definition and epidemiology","volume":"62","author":"Vander Borght","year":"2018","journal-title":"Clin Biochem"},{"key":"B66","doi-asserted-by":"publisher","first-page":":3822","DOI":"10.3390\/ijms20153822","article-title":"Progesterone and estrogen signaling in the endometrium: What goes wrong in endometriosis","volume":"20","author":"Marquardt","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1034614\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T15:39:11Z","timestamp":1674056351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1034614\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":66,"alternative-id":["10.3389\/fendo.2022.1034614"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1034614","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"article-number":"1034614"}}